Advantages of IgY
Haroldo ToroCa, Frederik W. van Ginkela, De-chu C. Tangb, Bettina Schemeraa, Soren Rodninga, and Joseph Newtona 2010, Avian Diseases 54(s1): 224-231.
aDepartment of Pathobiology, 264 Greene Hall, Auburn University, AL 36849
bVaxin Inc., 1500 1st Avenue North, Birmingham, AL 35203
Protective immunity to avian influenza (AI) virus can be elicited in chickens by in ovo or intramuscular vaccination with replication-competent adenovirus (RCA)-free human recombinant adenovirus serotype 5 (Ad5) encoding AI virus H5 (AdTW68.H5) or H7 (AdCN94.H7) hemagglutinins. We evaluated bivalent in ovo vaccination with AdTW68.H5 and AdCN94.H7 and determined that vaccinated chickens developed robust hemagglutination inhibition (HI) antibody levels to both H5 and H7 AI strains. Additionally, we evaluated immune responses of 1-day-old chickens vaccinated via spray with AdCN94.H7. These birds showed increased immunoglobulin A responses in lachrymal fluids and increased interleukin-6 expression in Harderian gland–derived lymphocytes. However, specific HI antibodies were not detected in the sera of these birds. Because pigs might play a role as a “mixing vessel” for the generation of pandemic influenza viruses we explored the use of RCA-free adenovirus technology to immunize pigs against AI virus. Weanling piglets vaccinated intramuscularly with a single dose of RCA-free AdTW68.H5 developed strong systemic antibody responses 3 wk postvaccination. Intranasal application of AdTW68.H5 in piglets resulted in reduced vaccine coverage, i.e., 33% of pigs (2/6) developed an antibody response, but serum antibody levels in those successfully immunized animals were similar to intramuscularly vaccinated animals.
*Note: The HRP-Goat anti-Chicken IgA used in this study is available from Gallus Immunotech in the Anti-Chicken Immunoglobulin Secondary Reagents section of our website. Look for product code AChIgA-HRP.
